MALAT1 and neoplasm: The positive control, compound 5 (Figure S5), reduced MALAT1 levels by 50%, as observed previously in MMTV-PyMT tumor organoids, and had a similar effect on lowering premature-only MALAT1 (Figure 6A,B, Table S10) [16].